Annals of Emergency Medicine
Volume 42, Issue 1 , Pages 124-135 , July 2003

Clinical policy: Critical issues in the evaluation and management of adult patients presenting with suspected lower-extremity deep venous thrombosis

References 

  1. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation. 1996;93(III):2212–2245
  2. Davies GS, Salzman EW. The pathogenesis of deep vein thrombosis. In:  Joist HJ,  Sherman LA editor. Venous and Arterial Thrombosis: Pathogenesis, Diagnosis, Prevention, and Therapy. New York, NY: : Grune & Stratton; 1979;p. 1–22 [III]
  3. Bell WR, Simon TL. Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment. Am Heart J. 1982;103(III):239–262
  4. Moser KM, Fedullo PF, LitteJohn JK, et al.  Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA. 1994;271(II):223–225
  5. American College of Emergency Physician . Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med. 2003;41(III):257–270
  6. American College of Emergency Physicians . Clinical policy for the initial approach to adults presenting with a chief complaint of chest pain, with no history of trauma. Ann Emerg Med. 1995;25(III):274–299
  7. American College of Emergency Physicians . Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. Ann Emerg Med. 2000;35(III):521–544
  8. Monreal M, Lafoz E, Ruiz J, et al.  Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest. 1991;99(II):280–283
  9. Hingorani A, Ascher E, Lorenson E, et al.  Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg. 1997;26(III):853–860
  10. American College of Chest Physicians. Consensus Committee on Pulmonary Embolism . Opinions regarding the diagnosis and management of venous thromboembolic disease. Chest. 1998;113(III):499–504
  11. Hyers TM, Agnelli G, Hull RD, et al.  Antithrombotic Therapy for Venous Thromboembolic disease. Chest. 2001;119(III):176S–193S
  12. Tapson VF, Carroll BA, Davidson BL, et al.  The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med. 1999;160(III):1043–1066
  13. Merli G, Spiro TE, Olsson CG, et al.  Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thrombolic disease. Ann Intern Med. 2001;134(I):191–202
  14. Hull RD, Raskob GE, Brant RF, et al.  Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group. Arch Intern Med. 2000;160(II):229–236
  15. Samama MM, Cohen AT, Darmon JY, et al.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin study Group. N Engl J Med. 1999;341(II):793–800
  16. Vinson DR, Berman DA. Outpatient treatment of deep venous thrombosis: a clinical care pathway managed by the emergency department. Ann Emerg Med. 2001;37(II):251–258
  17. Investigators PEP. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355(I):1295–1302
  18. Decousus H, Leizorovicz A, Parent F, et al.  A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338(II):409–415
  19. Douketis JD, Foster GA, Crowther MA, et al.  Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med. 2000;160(II):3431–3436
  20. Rutherford SE, Phelan JP. Deep venous thrombosis and pulmonary embolism in pregnancy. Obstet Gynecol Clin North Am. 1991;18(III):345–370
  21. Erdman WA, Jayson HT, Redman HC, et al.  Deep venous thrombosis of extremities: role of MR imaging in the diagnosis. Radiology. 1990;174(III):425–431
  22. Ghaye B, Szapiro D, Willems V, et al.  Combined CT venography of the lower limbs and spiral CT angiography of pulmonary arteries in acute pulmonary embolism: preliminary results of a prospective study. JBR-BTR. 2000;83(II):271–278
  23. Cham MD, Yankelevitz DF, Shaham D, et al.  Deep venous thrombosis: detection by using indirect CT venography. The Pulmonary Angiography-Indirect CT Venography Cooperative Group. Radiology. 2000;216(II):744–751
  24. Muto P, Lastoria S. Use of radiolabeled peptides to image deep venous thrombosis and pulmonary embolism. J Nucl Med. 2000;41(III):1065–1066
  25. Butler SP, Rahman T, Boyd SJ, et al.  Detection of postoperative deep-venous thrombosis using technetium-99m-labeled tissue plasminogen activator. J Nucl Med. 1997;38(II):219–223
  26. Klem JA, Schaffer JV, Crane PD, et al.  Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary report. J Nucl Cardiol. 2000;7(III):359–364
  27. Hull RD, Raskob GE, Ginsberg JS, et al.  A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med. 1994;154(II):289–297
  28. Stein PD, Hull RD, Pineo G. Strategy that includes serial noninvasive leg tests for diagnosis of thromboembolic disease in patients with suspected acute pulmonary embolism based on data from PIOPED. Prospective Investigation of Pulmonary Embolism Diagnosis. Arch Intern Med. 1995;155(III):2101–2104
  29. Ginsberg JS, Wells PS, Hirsh J, et al.  Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis. Arch Intern Med. 1994;154(II):1930–1933
  30. Kearon C, Julian JA, Newman TE, et al.  Noninvasive diagnosis of deep venous thrombosis. Ann Intern Med. 1998;128(III):663–677
  31. Turner IC, McNally MA, O'Connell BM, et al.  Numerical model of deep venous thrombosis detection using venous occlusion strain gauge plethysmography. Med Biol Eng Comput. 2000;38(III):348–355
  32. Warwick DJ, Thornton MJ, Freeman S, et al.  Computerized strain-gauge plethysmography in the diagnosis of symptomatic and asymptomatic venous thrombosis. Br J Radiol. 1994;67(III):938–940
  33. Maskell NA, Cooke S, Meecham Jones DJ, et al.  The use of automated strain gauge plethysmography in the diagnosis of deep vein thrombosis. Br J Radiol. 2002;75(II):648–651
  34. Kraaijenhagen RA, Lensing AW, Lijmer JG, et al.  Diagnostic strategies for the management of patients with clinically suspected deep-vein thrombosis. Curr Opin Pulm Med. 1997;3(II):265–267
  35. Schriger DL, Cantrill SV, Greene CS. The origins, benefits, harms, and implications of emergency medicine clinical policies. Ann Emerg Med. 1993;22(III):597–602
  36. Schulz KF, Chalmers I, Hayes RJ, et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(II):408–412
  37. Juni P, Witschi A, Bloch R, et al.  The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282(II):1054–1060
  38. Lijmer JG, Mol BW, Heisterkamp S, et al.  Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282(II):1061–1066
  39. Anand SS, Wells PS, Hunt D, et al.  Does this patient have deep vein thrombosis?. JAMA. 1998;279(III):1094–1099
  40. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271(III):703–707
  41. Gallagher EJ. Clinical utility of likelihood ratios. Ann Emerg Med. 1998;31(III):391–397
  42. Wells PS, Anderson DR, Bormanis J, et al.  Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet. 1997;350(II):1795–1798
  43. Bigaroni A, Perrier A, Bounameaux H. Is clinical probability assessment of deep vein thrombosis by a score really standardized?. Thromb Haemost. 2000;83(III):788–789
  44. Wells PS, Anderson DR. Diagnosis of deep-vein thrombosis in the year 2000. Curr Opin Pulm Med. 2000;6(III):309–313
  45. D'Angelo A, D'Alessandro G, Tomassini L, et al.  Evaluation of a new rapid quantitative D -dimer assay in patients with clinically suspected deep vein thrombosis. Thromb Haemost. 1996;75(II):412–416
  46. Dale S, Gogstadd GO, Brosstad F, et al.  Comparison of three D -dimer assays for the diagnosis of DVT: ELISA, latex and an immunofiltration assay (NycoCard D -dimer). Thromb Haemost. 1994;71(II):270–274
  47. Janssen MC, Heebels AE, de Metz M, et al.  Reliability of five rapid D -dimer assays compared to ELISA in the exclusion of deep venous thrombosis. Thromb Haemost. 1997;77(II):262–266
  48. Perrier A, Desmarais S, Miron MJ, et al.  Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet. 1999;353(II):190–195
  49. Knecht MF, Heinrich F. Clinical evaluation of an immunoturbidimetric D -dimer assay in the diagnostic procedure of deep vein thrombosis and pulmonary embolism. Thromb Res. 1997;88(II):413–417
  50. Leroyer C, Escoffre M, LeMoigne E, et al.  Diagnostic value of a new sensitive membrane based technique for instantaneous D -dimer evaluation in patients with clinically suspected deep venous thrombosis. Thromb Haemost. 1997;77(II):637–640
  51. Johna S, Cemaj S, O'Callaghan T, Catalano R. Effect of tissue injury on D -dimer levels: a prospective study in trauma patients. Med Sci Monit. 2002;8(III):CR5–CR8
  52. Owings JT, Gosselin RC, Anderson JT, et al.  Practical utility of the D -dimer assay for excluding thromboembolism in severely injured trauma patients. J Trauma. 2001;51(II):425–429
  53. Brown MD, Rowe BH, Reeves MJ, et al.  The accuracy of the enzyme-linked immunosorbent assay D -dimer test in the diagnosis of pulmonary embolism. Ann Emerg Med. 2002;40(II):133–144
  54. Schutghens RJ, Esseboom EU, Haas FJ, et al.  Usefulness of a semiquantitative D -dimer test for the exclusion of deep venous thrombosis in outpatients. Am J Med. 2002;112(II):617–621
  55. Oger E, Leroyer C, Bressollette L, et al.  Evaluation of a new, rapid, and quantitative D -dimer test in patients with suspected pulmonary embolism. Am J Respir Crit Care Med. 1998;158(II):65–70
  56. Veitl M, Hamwi A, Kurtaran A, et al.  Comparison of four rapid D -dimer tests for diagnosis of pulmonary embolism. Thromb Res. 1996;82(II):399–407
  57. Duet M, Benelhadj S, Kedra W, et al.  A new quantitative D -dimer assay appropriate in emergency: reliability of the assay for pulmonary embolism exclusion diagnosis. Thromb Res. 1998;91(II):1–5
  58. Gosselin RC, Owings JT, Utter GH, et al.  A new method for measuring D -dimer using immunoturbidometry: a study of 255 patients with suspected pulmonary embolism and deep vein thrombosis. Blood Coagul Fibrinolysis. 2000;11(II):715–721
  59. Legnani C, Pancani C, Palareti G, et al.  Contribution of a new, rapid, quantitative and automated method for D -dimer measurement to exclude deep vein thrombosis in symptomatic outpatients. Blood Coagul Fibrinolysis. 1999;10(II):69–74
  60. Keeling DM, Wright M, Baker P, et al.  D -Dimer for the exclusion of venous thromboembolism: comparison of a new automated latex particle immunoassay (MDA D -dimer) with an established enzyme-linked fluorescent assay (VIDAS D -dimer). Clin Lab Haematol. 1999;21(III):359–362
  61. Freyburger G, Trillaud H, Labrouche S, et al.  D -dimer strategy in thrombosis exclusion—a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared. Thromb Haemost. 1998;79(III):32–37
  62. Hansson PO, Eriksson H, Eriksson E, et al.  Can laboratory testing improve screening strategies for deep vein thrombosis at an emergency unit?. J Intern Med. 1994;235(II):143–151
  63. Kozman H, Flemmer MC, Rahnama M. Deep venous thrombosis: prediction by D -dimer?. South Med J. 1997;90(II):907–910
  64. Bongard O, Wicky J, Peter R, et al.  D -Dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal vein thrombosis. Thromb Res. 1994;74(III):487–493
  65. Bounameaux H, Schneider PA, Reber G, et al.  Measurement of plasma D -dimer for diagnosis of deep venous thrombosis. Am J Clin Pathol. 1989;91(II):82–85
  66. de Moerloose P, Desmarais S, Bounameaux H, et al.  Contribution of a new, rapid, individual and quantitative automated D -dimer ELISA to exclude pulmonary embolism. Thromb Haemost. 1996;75(II):11–13
  67. Mauron T, Baumgartner I, Z'Brun A, et al.  SimpliRED D -dimer assay: comparability of capillary and citrated venous whole blood, between-assay variability, and performance of the test for exclusion of deep venous thrombosis in symptomatic outpatients. Thromb Haemost. 1998;79(III):1217–1219
  68. Wells PS, Anderson DR, Bormanis J, et al.  SimpliRED D- dimer can reduce the diagnostic tests in suspected deep vein thrombosis. Lancet. 1998;351(III):1405–1406
  69. Wildberger JE, Vorwerk D, Kilbinger M, et al.  Bedside testing (SimpliRED) in the diagnosis of deep vein thrombosis. Evaluation of 250 patients. Invest Radiol. 1998;33(II):232–235
  70. Wells PS, Brill-Edwards P, Stevens P, et al.  A novel and rapid whole-blood assay for D -dimer in patients with clinically suspected deep vein thrombosis. Circulation. 1995;91(II):2184–2187
  71. Dryjski M, O'Brien-Irr MS, Harris LM, et al.  Evaluation of a screening protocol to exclude the diagnosis of deep venous thrombosis among emergency department patients. J Vasc Surg. 2001;34(II):1010–1015
  72. Lennox AF, Konstantinos TD, Serunkuma S, et al.  Combination of a clinical risk assessment score and rapid whole blood D -dimer testing in the diagnosis of deep vein thrombosis in symptomatic patients. J Vasc Surg. 1999;30(II):794–804
  73. Cornuz J, Ghali WA, Hayoz D, et al.  Clinical prediction of deep venous thrombosis using two risk assessment methods in combination with rapid quantitative D -dimer testing. Am J Med. 2002;112(II):198–203
  74. Anderson DR, Wells PS, Stiell I, et al.  Management of patients with suspected deep vein thrombosis in the emergency department: combining use of a clinical diagnosis model with D -dimer testing. J Emerg Med. 2000;19(II):225–230
  75. Kraaijenhagen RA, Piovella F, Bernardi E, et al.  Simplification of the diagnostic management of suspected deep vein thrombosis. Arch Intern Med. 2002;162(II):907–911
  76. Farrell S, Hayes T, Shaw M. A negative SimpliRED D -dimer assay result does not exclude the diagnosis of deep vein thrombosis or pulmonary embolus in emergency department patients. Ann Emerg Med. 2000;35(II):121–125
  77. Kline JA, Johns KL, Colucciello SA, et al.  New diagnostic tests for pulmonary embolism. Ann Emerg Med. 2000;35(III):168–180
  78. Reber G, Bounameaux H, Perrier A, et al.  Evaluation of advanced D -dimer assay for the exclusion of venous thromboembolism. Thromb Res. 2002;107(III):197–200
  79. Kearon C, Julian JA, Newman TE, et al.  Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med. 1998;128(II):663–677
  80. Lensing AW, Prandoni P, Brandjes D, et al.  Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med. 1989;320(II):342–345
  81. Killewich LA, Bedford GR, Beach KW, et al.  Diagnosis of deep venous thrombosis. A prospective study comparing duplex scanning to contrast venography. Circulation. 1989;79(II):810–814
  82. Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med. 1998;129(III):1044–1049 Review
  83. Daniel KR, Jackson RE, Kline JA. Utility of lower extremity venous ultrasound in the diagnosis and exclusion of pulmonary embolism in outpatients. Ann Emerg Med. 2000;35(II):547–554
  84. Gottlieb RH, Widjaja J, Mehra S, et al.  Clinically important pulmonary emboli: does calf vein US alter outcomes?. Radiology. 1999;211(II):25–29
  85. Masuda EM, Kessler DM, Kistner RL, et al.  The natural history of calf vein thrombosis: lysis of thrombi and development of reflux. J Vasc Surg. 1998;28(II):67–73
  86. Meissner MH, Caps MT, Bergelin RO, et al.  Early outcome after isolated calf vein thrombosis. J Vasc Surg. 1997;26(II):749–756
  87. McLafferty RB, Moneta GL, Passman MA, et al.  Late clinical and hemodynamic sequelae of isolated calf vein thrombosis. J Vasc Surg. 1998;27(III):50–56
  88. Passman MA, Moneta GL, Taylor LM, et al.  Pulmonary embolism is associated with the combination of isolated calf vein thrombosis and respiratory symptoms. J Vasc Surg. 1997;25(II):39–45
  89. Lagerstedt CI, Olsson CG, Fagher BO, et al.  Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet. 1985;2(II):515–518
  90. Kazmers A, Groehn H, Meeker C. Acute calf vein thrombosis. Am Surg. 1999;65(II):1124–1127
  91. Ohgi S, Tachibana M, Ikebuchi M, et al.  Pulmonary embolism in patients with isolate soleal vein thrombosis. Angiology. 1998;49(III):759–764
  92. Schwarz T, Schmidt B, Beyer J, et al.  Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin. Blood Coag Fibrinolysis. 2001;12(III):597–599
  93. Astermark J, Bjorgell O, Linden E, et al.  Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation. J Intern Med. 1998;244(II):79–82
  94. Pinede L, Ninet J, Duhaut P, et al.  Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation. 2001;103(II):2453–2460
  95. Pinede L, Cucherat M, Duhaut P, et al.  Optimal duration of anticoagulant therapy after an episode of venous thromboembolism. Blood Coagul Fibrinolysis. 2000;11(III):701–708
  96. Wells PS, Ginsberg JS, Anderson DR, et al.  Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med. 1998;129(II):997–1005
  97. Heijboer H, Buller HR, Lensing A, et al.  A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med. 1993;329(I):1365–1369
  98. Birdwell BG, Raskob GE, Whitsett TL, et al.  The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med. 1998;128(II):1–7
  99. Kanter DS, Mikkola KM, Patel SR, et al.  Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest. 1997;111(II):1241–1245
  100. O'Meara JJ, McNutt RA, Evans AT, et al.  A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med. 1994;330(III):1864–1869
  101. Schweizer J, Kirch W, Koch R, et al.  Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol. 2000;36(II):1336–1343
  102. Comerota AJ, Throm RC, Mathias SD, et al.  Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000;32(II):130–137
  103. Goldhaber SZ, Buring JE, Lipnick RJ, et al.  Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med. 1984;76(II):393–397
  104. Elliot MS, Immelman EJ, Jeffery P, et al.  A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal vein thrombosis: an interim report of a prospective trial. Br J Surg. 1979;66(II):838–843
  105. Ouriel K, Katzen B, Mewissen M, et al.  Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study. J Vasc Interv Radiol. 2000;11(II):849–854
  106. Schweizer J, Elix H, Altmann E, et al.  Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study. Vasa. 1998;27(III):167–171
  107. Martin M, Heimig T, Fiebach BJ, et al.  Fibrinolytic treatment with ultra-high streptokinase infusion via the dorsalis pedis vein offers no advantage over systemic infusion via the brachial vein in patients with deep vein thrombosis of the leg. Vasa. 1996;25(II):275–278
  108. Manco-Johnson MJ, Nuss R, Hays T, et al.  Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr. 2000;136(II):446–453

☆ Policy statements and clinical policies are the official policies of the American College of Emergency Physicians and, as such, are not subject to the same peer review process as articles appearing in the journal. Policy statements and clinical policies of ACEP do not necessarily reflect the policies and beliefs of Annals of Emergency Medicine and its editors.

☆☆ This clinical policy was developed by the ACEP Clinical Policies Committee and the Clinical Policies Subcommittee on Suspected Lower-Extremity Deep Venous Thrombosis. For a complete listing of subcommittee and committee members, please seepage 131.

★ Approved by the ACEP Board of Directors, February 18, 2003.

PII: S0196-0644(03)00197-5

doi: 10.1067/mem.2003.181

Annals of Emergency Medicine
Volume 42, Issue 1 , Pages 124-135 , July 2003

Article Tools